Tetra Therapeutics is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression and schizophrenia.
For more details on financing and valuation for Tetra, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
To read this article and more news on Tetra, register or login.
